Study identifier:NIS-GRO-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A prospective, non-interventional study to evaluate the change in symptoms scores and treatment response after 4 weeks of systematic treatment with PPIs in GERD patients in primary care setting in Romania, using the validated GerdQ questionnaire.
Gastroesophageal reflux disease (GERD)
-
No
-
All
952
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|